Preeclampsia & eclampsia

Last updated: July 19, 2023

Preeclampsia & eclampsia

Dr. Andrews

Dr. Andrews

Cell cycle
Oncogenes and tumor suppressor genes
Non-Hodgkin lymphoma
Hodgkin lymphoma
DiGeorge syndrome
Hydronephrosis
Acute pyelonephritis
Chronic pyelonephritis
Vesicoureteral reflux
Bladder exstrophy
BK virus (Hemorrhagic cystitis)
Non-urothelial bladder cancers
Development of the umbilical cord
Development of the fetal membranes
Dizziness and vertigo: Clinical
Reactive arthritis
Klinefelter syndrome
Testicular tumors: Pathology review
DNA alkylating medications
Androgens and antiandrogens
PDE5 inhibitors
Adrenergic antagonists: Alpha blockers
Estrogens and antiestrogens
Progestins and antiprogestins
Aromatase inhibitors
Uterine stimulants and relaxants
Anatomy of the pelvic cavity
Pelvic inflammatory disease
Vulvar cancer: Clinical
Vaginal and vulvar disorders: Pathology review
Chlamydia trachomatis
Papulosquamous skin disorders: Clinical
Transitional cell carcinoma
Human papillomavirus
Paget disease of the breast
Vascular tumors
Development of the digestive system and body cavities
Nephroblastoma (Wilms tumor)
Development of the renal system
Antimetabolites for cancer treatment
Hypothyroidism: Pathology review
Hashimoto thyroiditis
Hyperthyroidism: Pathology review
Thyroid cancer
Thyroid nodules and thyroid cancer: Pathology review
Riedel thyroiditis
Waterhouse-Friderichsen syndrome
Hyperaldosteronism
Adrenal masses and tumors: Clinical
Sheehan syndrome
Cervical cancer
Ovarian cyst
Pheochromocytoma
Multiple endocrine neoplasia: Pathology review
Carcinoid syndrome
Vaginal cancer: Clinical
Acromegaly
Multiple endocrine neoplasia
Parathyroid hormone
Cystic fibrosis
Preeclampsia & eclampsia
Necrotizing enterocolitis
Neonatal respiratory distress syndrome
Galactosemia
Phenylketonuria (NORD)
WAGR syndrome
Focal segmental glomerulosclerosis (NORD)
Nephrotic syndromes: Pathology review
Membranoproliferative glomerulonephritis
Nephritic syndromes: Pathology review
IgA nephropathy (NORD)
Diabetic nephropathy
Membranous nephropathy
Minimal change disease
Ribonucleotide reductase inhibitors
Alport syndrome
Rapidly progressive glomerulonephritis
Goodpasture syndrome
Neurogenic bladder
Polycystic ovary syndrome
Endometrial hyperplasia
Renal system anatomy and physiology
Medullary cystic kidney disease
Krukenberg tumor
Polycystic kidney disease
Multicystic dysplastic kidney
Medullary sponge kidney
Horseshoe kidney
The role of the kidney in acid-base balance
Pancreatic cancer
Pancreatic neuroendocrine neoplasms
Acute pancreatitis
Chronic pancreatitis
Microtubule inhibitors
Bordetella pertussis (Whooping cough)
Topoisomerase inhibitors
Breast cancer
Prostate disorders and cancer: Pathology review
Antidiuretic hormone
Estrogen and progesterone
Li-Fraumeni syndrome
Renal agenesis
Gene regulation
Familial adenomatous polyposis
Mendelian genetics and punnett squares
Uterine fibroid
Respiratory acidosis
Legionella pneumophila (Legionnaires disease and Pontiac fever)
Antituberculosis medications
Cell wall synthesis inhibitors: Cephalosporins
Cell wall synthesis inhibitors: Penicillins
Peutz-Jeghers syndrome
Anatomy of the perineum

Transcript

Watch video only

Preeclampsia is a disorder that only happens in pregnant women, and it happens after 20 weeks’ gestation, and in some cases develops up to 6 weeks after delivery.

Preeclampsia causes new-onset hypertension and proteinuria, which is a marker of kidney damage, and can also cause damage to other organs like the brain and liver.

There can be a wide range of symptoms. For some women there may be no symptoms or only mild ones, whereas for others, it can turn into a life-threatening illness.

If a woman with preeclampsia develops seizures, she is then said to have eclampsia.

Preeclampsia tends to occur more often during a first pregnancy, in pregnancies with multiple gestations, or in mothers 35 years or older.

Other risk factors include having hypertension, diabetes, obesity, or a family history of preeclampsia.

Alright, but why do these changes happen in preeclampsia and eclampsia?

Well, the exact cause is unclear, but a key pathophysiologic feature though is the development of an abnormal placenta.

Normally, during pregnancy, the spiral arteries dilate to 5-10 times their normal size and develop into large uteroplacental arteries that can deliver large quantities of blood to the developing fetus.

In preeclampsia, these uteroplacental arteries become fibrous causing them to narrow, which means less blood gets to the placenta.

A poorly perfused placenta can lead to intrauterine growth restriction and even fetal death in severe cases.

This hypoperfused placenta starts releasing pro-inflammatory proteins.

These then get into the mother’s circulation and cause the endothelial cells that line her blood vessels to become dysfunctional.

Endothelial cell dysfunction causes vasoconstriction—narrowing of the blood vessels—and also affects the kidneys in a way that makes them retain more salt, both of which result in hypertension.

When diagnosing preeclampsia, hypertension is defined as a systolic blood pressure of 140 mmHg or greater or diastolic blood pressure of 90 mmHg or greater.

In severe preeclampsia, systolic blood pressure can be 160 mmHg or greater and diastolic blood pressure can be 110 mmHg or greater.

These extreme blood pressures can lead to a hemorrhagic stroke or placental abruption, which the placenta detaches prematurely from the uterine wall.

Now, there can also be local areas of vasospasm, which means that less blood might reach certain parts of the body.

For example, reduced blood flow to the kidneys, which are particularly susceptible, can cause glomerular damage leading to oliguria—which is abnormally low amounts of urine, as well as proteinuria.

Normally, the glomeruli of the kidneys do a good job of preventing protein from spilling into the urine, so proteinuria can be a sign of glomerular damage and is a classic sign of preeclampsia.

Key Takeaways

Preeclampsia and eclampsia are two separate, but related, conditions that occur during pregnancy. Preeclampsia is characterized by hypertension and proteinuria presenting after 20 weeks of gestation and can worsen over time. In severe disease, there may be hemolysis, a low blood platelet count, impaired liver function, kidney dysfunction, shortness of breath due to fluid in the lungs, and visual disturbances.

If left untreated, preeclampsia can lead to eclampsia, a more serious condition in which the woman experiences convulsions or seizures. Treatment for preeclampsia and eclampsia typically involves a combination of bed rest and medications such as antihypertensives and magnesium sulfate, which helps to prevent seizures. In some cases, the delivery of the baby may be required.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Hypertension in Pregnancy" Obstetrics & Gynecology (2013)
  6. "Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis" BMJ (2014)
  7. "A Comprehensive Review of Hypertension in Pregnancy" Journal of Pregnancy (2012)